National Atomic Company Kazatomprom JSC (KZAP) Q2 2026 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 TU earnings summary
3 Aug, 2026Executive summary
Second quarter and half-year 2026 update highlights operational and trading results, with a focus on uranium market developments and company performance.
Global nuclear sector saw major investments, regulatory milestones, and new project launches, supporting robust uranium demand.
Company completed 2025 dividend payment and maintained Board composition, with a partial bond redemption executed.
Market and industry conditions
U.S. government approved $17.5 billion in loans for domestic nuclear supply chain, supporting new reactor builds.
Significant progress in SMR projects in the U.S., Russia, Uzbekistan, and the UK, with new plants and regulatory approvals.
UK banned Russian-origin uranium imports, with exemptions for certain cases; Australia and India expanded uranium trade.
New uranium mining projects launched in Mongolia, Uzbekistan, Canada, and the U.S.; Cameco resumed Cigar Lake operations after a brief suspension.
Uranium spot price averaged $85.98/lb in 1H2026, up from $69.11/lb in 1H2025; spot transaction volumes rose 19% year-over-year.
Long-term contract volumes increased to 32.5 million lbs in 1H2026, with average long-term price up $15.50/lb year-over-year to $95.50/lb.
Financial highlights
Group U3O8 production (100% basis) rose 8% in Q2 and 9% in 1H2026 year-over-year; attributable production up 10% for both periods.
Group U3O8 sales volume up 19% in Q2 and flat in 1H2026; KAP sales volume up 3% in Q2 but down 13% in 1H2026 due to delivery timing.
Group average realized price increased 17% in Q2 and 16% in 1H2026; KAP average realized price up 14% in Q2 and 13% in 1H2026.
2025 dividend of KZT 335.16 billion paid to shareholders in July 2026.
Latest events from National Atomic Company Kazatomprom JSC
- Higher 9M output and prices; 2026 guidance unchanged as uranium markets tightened.KZAP
Q3 2026 TU - Higher realized prices and raised sales guidance offset disciplined, lower production volumes.KZAP
H1 2023 - Higher uranium prices lifted FY2023 revenue as 2024 guidance targets increased output and investment.KZAP
H2 2023 - Revenue up 9% YoY, net profit down 9%, with higher costs and strong uranium leadership.KZAP
Q2 2026 - Revenue and profit fell on lower uranium sales, but a major dividend was approved.KZAP
Q1 2026 - Production up, sales down, prices higher; 2026 guidance steady amid robust nuclear demand.KZAP
Q1 2026 TU - Revenue fell but operating profit and production rose, with strong liquidity and growth plans.KZAP
Q2 2025 - H1 revenue and net profit climbed; 2025 output plans were curtailed by supply constraints.KZAP
Q2 2024 - 2024 net profit nearly doubled on uranium price strength and one-off gains; 2025 outlook robust.KZAP
Q4 2024